Thursday, August 13, 2020 3:15:16 AM
That is PAOG and RBII cuz last i remember PAOG owned rights to RBII's Cannophen in exchange for facilities but the Karl Reidell fiasco still is unexplained and people here are sayen he is selling Cannophen independently w his own private company and severed ties w pao and RBII which is very strange/suspicious imo. The new product oxy thyme is excellent but now that the q2 earnings report is late and the Cannophen issue has not been addressed i wouldnt be surprised if this tests support levels at .008-.005 until q3 earnings release
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM